Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.43 |
| ▸ | CNR1 | P21554 | 8/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5047213 | 1.00 | CNR2 (0.43) | CNR2CNR1EPHX2 | |
| SCHEMBL965710 | 0.92 | CNR2 (0.36) | CNR2CNR1EPHX2 | |
| SCHEMBL965708 | 0.92 | CNR2 (0.36) | CNR2CNR1EPHX2 | |
| SCHEMBL961525 | 0.88 | CNR2 (0.45) | CNR2CNR1 | |
| SCHEMBL961527 | 0.88 | CNR2 (0.45) | CNR2CNR1 | |
| SCHEMBL961974 | 0.82 | CNR2 (0.36) | CNR2CNR1 | |
| SCHEMBL961976 | 0.82 | CNR2 (0.36) | CNR2CNR1 | |
| SCHEMBL967895 | 0.81 | CNR2 (0.38) | CNR2CNR1EPHX2 | |
| SCHEMBL967896 | 0.81 | CNR2 (0.38) | CNR2CNR1EPHX2 | |
| SCHEMBL965811 | 0.81 | CNR2 (0.46) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064699-A1 | Such as N-[3-(2-methoxyethyl)-1,3-thiazol-2(3H)-ylidene]adamantane-1-carboxamide; neuropathic, nociceptive and/or inflammatory pain; neuroprotection | ABBVIE INC. | 2008-03-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064699-A1 | Such as N-[3-(2-methoxyethyl)-1,3-thiazol-2(3H)-ylidene]adamantane-1-carboxamide; neuropathic, nociceptive and/or inflammatory pain; neuroprotection | OPRL1, OPRK1, OPRD1 | CNR2 5/4885CNR1 10/4885EPHX2 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.